NFE2L2 and nonpapillary renal cell carcinoma: Other newly identified pathways and components frequently mutated in ccRCC include the PI3K-AKT-mTOR signaling pathway, DNA methylation processes, p53-related pathways, mRNA processing mechanisms, and the KEAP1-NRF2-CUL3 complex [87].